Multi-Center Comparison of Two Self-Expanding Transcatheter Heart Valves: A Propensity Matched Analysis
Authors:
- Johannes BlumensteinJBJohannes Blumenstein
- Clemens EckelCEClemens Eckel
- Oliver HusserOHOliver Husser
- Won-Keun KimWKWon-Keun Kim
- Matthias RenkerMRMatthias Renker
- Yeong-Hoon ChoiYCYeong-Hoon Choi
- Christian W. HammCHChristian W. Hamm
- Hani Al-TerkiHAHani Al-Terki
- Dagmar SötemannDSDagmar Sötemann
- Leon KörbiLKLeon Körbi
- Vedat TiyeriliVTVedat Tiyerili
- Christina GrothusenCGChristina Grothusen
Open Access
- 21 July 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (14) , 4228
Abstract
Background: During the last years, several transcatheter aortic heart valves entered the clinical market and are commercially available. The prostheses differ regarding several technical and functional aspects. However, little is known regarding head-to-head comparative data of the ACURATE neo and the PORTICO valve prostheses. Objectives: The aim of this study was to compare two self-expanding transcatheter aortic heart valves (THV), the ACURATE neo and the PORTICO, with regard to in-hospital and 30-day outcomes, as well as early device failures. Methods: A total of 1591 consecutive patients with severe native aortic valve stenosis from two centers were included in the analyses and matched by 1:1 nearest neighbor matching to identify one patient treated with PORTICO (n = 344) for each patient treated with ACURATE neo (n = 344). Results: In-hospital complications were comparable between both valves, including any kind of stroke (ACURATE neo = 3.5% vs. PORTICO = 3.8%; p = 1.0), major vascular complications (ACURATE neo = 4.5% vs. PORTICO = 5.4%; p = 0.99) or life-threatening bleeding (ACURATE neo = 1% vs. PORTICO = 2%; p = 0.68). The rate of device failure defined by the VARC-2 criteria were comparable, including elevated gradients and moderate-to-severe paravalvular leakage (ACURATE neo = 7.3% vs. PORTICO = 7.6%; p = 1.0). However, the need for permanent pacemaker implantation (PPI) was significantly more frequent after the use of PORTICO THV (9.5% vs. 18.7%; p = 0.002). Conclusions: In this two-center case-matched comparison, short-term clinical and hemodynamic outcomes showed comparable results between PORTICO and ACURATE neo prostheses. However, PORTICO was associated with a significant higher incidence of PPI.Keywords
This publication has 40 references indexed in Scilit:
- Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve ReplacementCirculation: Cardiovascular Interventions, 2016
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk PatientsNew England Journal of Medicine, 2016
- Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomesEuropean Heart Journal, 2014
- Predictors of Permanent Pacemaker Implantation in Patients With Severe Aortic Stenosis Undergoing TAVRJACC, 2014
- Comparison of Balloon-Expandable vs Self-expandable Valves in Patients Undergoing Transcatheter Aortic Valve ReplacementJAMA, 2014
- Symetis ACURATE TF™ aortic bioprosthesisEuroIntervention, 2013
- SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR)Journal of Cardiovascular Computed Tomography, 2012
- Transcatheter Aortic Valve Replacement With the St. Jude Medical Portico ValveJACC, 2012
- Clinical Outcomes After Transcatheter Aortic Valve Replacement Using Valve Academic Research Consortium DefinitionsJACC, 2012
- Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk PatientsNew England Journal of Medicine, 2011